BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...the minimum threshold of 66.7%.  Laboratoris Sanifit S.L. hired Adam Levy as CFO. He was CBO of Brickell Biotech Inc....
BioCentury | Jan 3, 2019
Distillery Therapeutics

Cancer

...for multiple sclerosis (MS), traumatic brain injury (TBI), Alzheimer's disease (AD) and Parkinson's disease (PD). Brickell Biotech Inc....
BioCentury | Nov 19, 2018
Company News

Management tracks: Brickell, Genevant

...Dermatology company Brickell Biotech Inc. (Boulder, Colo.) hired Robert Brown as CEO, effective Jan. 1. He will replace...
BioCentury | Feb 16, 2018
Clinical News

Brickell's sofpironium bromide meets in Phase IIb for hyperhidrosis

...In October, Brickell Biotech Inc. (Boulder, Colo.) reported data from a double-blind, U.S. Phase IIb trial in 227...
...and certain other Asian countries from Brickell to develop and commercialize the topical soft anticholinergic. Brickell Biotech Inc....
...Life Quality Index (DLQI) score Status: Phase IIb data Milestone: Start Phase III (2018) Claire Quang BBI-4000 Sofpironium bromide Brickell Biotech Inc....
BioCentury | Oct 27, 2016
Distillery Therapeutics

Cancer

...International Inc. market Targretin bexarotene, an RXR agonist, to treat cutaneous T cell lymphoma (CTCL). Brickell Biotech Inc....
BioCentury | Jan 4, 2016
Clinical News

Sofpironium bromide: Phase IIb data

...rights in Japan and certain other Asian countries from Brickell to develop and commercialize BBI-4000. Brickell Biotech Inc....
BioCentury | Jan 4, 2016
Company News

Orca Pharmaceuticals, New York University, Brickell Biotech deal

...to inquiries. Orca Pharmaceuticals Ltd. , Oxford, U.K. New York University , New York, N.Y. Brickell Biotech Inc....
BioCentury | Jul 9, 2015
Company News

Management tracks

...named Diane Young CMO. She was a VP at Novartis AG (NYSE:NVS; SIX:NOVN). Dermatology play Brickell Biotech Inc....
BioCentury | May 19, 2015
Company News

Management tracks

...Inc. (NASDAQ:SCYX) named David Angulo CMO, effective June 1. Augulo was VP of R&D at Brickell Biotech Inc....
BioCentury | Feb 16, 2015
Clinical News

BBI-4000: Phase IIb started

...3 dose levels of topical BBI-4000 once daily for 4 weeks in about 180 patients. Brickell Biotech Inc....
Items per page:
1 - 10 of 16
BioCentury | Aug 22, 2020
Management Tracks

Qiagen chairman steps down, plus changes at Sanifit and Xeris

...the minimum threshold of 66.7%.  Laboratoris Sanifit S.L. hired Adam Levy as CFO. He was CBO of Brickell Biotech Inc....
BioCentury | Jan 3, 2019
Distillery Therapeutics

Cancer

...for multiple sclerosis (MS), traumatic brain injury (TBI), Alzheimer's disease (AD) and Parkinson's disease (PD). Brickell Biotech Inc....
BioCentury | Nov 19, 2018
Company News

Management tracks: Brickell, Genevant

...Dermatology company Brickell Biotech Inc. (Boulder, Colo.) hired Robert Brown as CEO, effective Jan. 1. He will replace...
BioCentury | Feb 16, 2018
Clinical News

Brickell's sofpironium bromide meets in Phase IIb for hyperhidrosis

...In October, Brickell Biotech Inc. (Boulder, Colo.) reported data from a double-blind, U.S. Phase IIb trial in 227...
...and certain other Asian countries from Brickell to develop and commercialize the topical soft anticholinergic. Brickell Biotech Inc....
...Life Quality Index (DLQI) score Status: Phase IIb data Milestone: Start Phase III (2018) Claire Quang BBI-4000 Sofpironium bromide Brickell Biotech Inc....
BioCentury | Oct 27, 2016
Distillery Therapeutics

Cancer

...International Inc. market Targretin bexarotene, an RXR agonist, to treat cutaneous T cell lymphoma (CTCL). Brickell Biotech Inc....
BioCentury | Jan 4, 2016
Clinical News

Sofpironium bromide: Phase IIb data

...rights in Japan and certain other Asian countries from Brickell to develop and commercialize BBI-4000. Brickell Biotech Inc....
BioCentury | Jan 4, 2016
Company News

Orca Pharmaceuticals, New York University, Brickell Biotech deal

...to inquiries. Orca Pharmaceuticals Ltd. , Oxford, U.K. New York University , New York, N.Y. Brickell Biotech Inc....
BioCentury | Jul 9, 2015
Company News

Management tracks

...named Diane Young CMO. She was a VP at Novartis AG (NYSE:NVS; SIX:NOVN). Dermatology play Brickell Biotech Inc....
BioCentury | May 19, 2015
Company News

Management tracks

...Inc. (NASDAQ:SCYX) named David Angulo CMO, effective June 1. Augulo was VP of R&D at Brickell Biotech Inc....
BioCentury | Feb 16, 2015
Clinical News

BBI-4000: Phase IIb started

...3 dose levels of topical BBI-4000 once daily for 4 weeks in about 180 patients. Brickell Biotech Inc....
Items per page:
1 - 10 of 16